The last transaction price of Eltrombopag/Eltrombopag ethanolamine tablets

Eltrombopag/Eltrombopag is an oral, small molecule, non-peptide thrombopoietin receptor agonist. It is approved to treat thrombocytopenia to increase platelet counts and protect patients from bleeding. It is generally very well tolerated orally and has an excellent safety profile, with approximately 60%-80% of patients experiencing an overall positive response and improvement. Response to eltrombopag was followed by multiple measurements of platelet counts. The dose is then adjusted to achieve adequate platelet counts to avoid thrombocytopenia and thrombocytosis. Eltrombopag can be used alone or in combination with other drugs for the first- or second-line treatment of idiopathic thrombocytopenia (ITP).

The original drug of Eltrombopag is sold in China under the name of Eltrombopag ethanolamine tablets. Common specifications include 25mg*14 tablets and 25mg*28 tablets per box. The price of each box is about 2,000 to 4,000 yuan, and it can be included in the reimbursement scope of Class B medical insurance. However, only patients who meet the indications can receive reimbursement, and patients who do not meet the requirements can only purchase the drug at their own expense. Eltrombopag's original drug is sold overseas in Turkish and Indian versions, and the price of each box may be around 1,000 yuan (the price may fluctuate due to exchange rates).

In addition, there are generic eltrombopag drugs produced in other countries on the market overseas, and their drug ingredients are basically the same as the original drugs sold at home and abroad. Common generic drug manufacturers include Bangladesh Yaopin International, Laos Lucius Pharmaceuticals and IndiaNATCO Pharmaceutical Factory, etc. The price of each box sold may be around a few hundred RMB (the price may fluctuate due to exchange rates).